MY148945A - Combination of a betamimetic with anticholinergics and/or steroids - Google Patents

Combination of a betamimetic with anticholinergics and/or steroids

Info

Publication number
MY148945A
MY148945A MYPI20051739A MYPI20051739A MY148945A MY 148945 A MY148945 A MY 148945A MY PI20051739 A MYPI20051739 A MY PI20051739A MY PI20051739 A MYPI20051739 A MY PI20051739A MY 148945 A MY148945 A MY 148945A
Authority
MY
Malaysia
Prior art keywords
betamimetic
anticholinergics
steroids
combination
preparing
Prior art date
Application number
MYPI20051739A
Other languages
English (en)
Inventor
Ingo Konetzki
Thierry Bouyssou
Philipp Lustenberger
Michael P Pieper
Andreas Schnapp
Christoph Hoenke
Sabine Pestel
Klaus Rudolf
Michel Pairet
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34966478&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY148945(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE102004019540A external-priority patent/DE102004019540A1/de
Priority claimed from DE102004052987A external-priority patent/DE102004052987A1/de
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of MY148945A publication Critical patent/MY148945A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pregnancy & Childbirth (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Transplantation (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MYPI20051739A 2004-04-22 2005-04-20 Combination of a betamimetic with anticholinergics and/or steroids MY148945A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004019540A DE102004019540A1 (de) 2004-04-22 2004-04-22 Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
DE102004052987A DE102004052987A1 (de) 2004-11-03 2004-11-03 Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
EP05002496 2005-02-07

Publications (1)

Publication Number Publication Date
MY148945A true MY148945A (en) 2013-06-14

Family

ID=34966478

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20051739A MY148945A (en) 2004-04-22 2005-04-20 Combination of a betamimetic with anticholinergics and/or steroids

Country Status (33)

Country Link
EP (2) EP2422786B1 (OSRAM)
JP (1) JP2007533683A (OSRAM)
KR (2) KR101287460B1 (OSRAM)
AR (1) AR049262A1 (OSRAM)
AT (1) ATE539754T1 (OSRAM)
AU (1) AU2005235419B2 (OSRAM)
BE (1) BE2015C065I2 (OSRAM)
BR (1) BRPI0510080B8 (OSRAM)
CA (1) CA2559699C (OSRAM)
CY (3) CY1113890T1 (OSRAM)
DK (2) DK1781298T3 (OSRAM)
EA (1) EA013157B1 (OSRAM)
EC (1) ECSP066947A (OSRAM)
ES (2) ES2523518T3 (OSRAM)
FI (1) FIC20170005I1 (OSRAM)
FR (1) FR16C0029I2 (OSRAM)
HU (1) HUS1500058I1 (OSRAM)
IL (2) IL177685A (OSRAM)
LT (1) LTC1781298I2 (OSRAM)
LU (1) LU93066I2 (OSRAM)
MY (1) MY148945A (OSRAM)
NL (1) NL300779I2 (OSRAM)
NO (2) NO337714B1 (OSRAM)
NZ (1) NZ550797A (OSRAM)
PE (1) PE20060462A1 (OSRAM)
PL (2) PL2422786T3 (OSRAM)
PT (2) PT1781298E (OSRAM)
SG (1) SG152237A1 (OSRAM)
SI (2) SI2422786T1 (OSRAM)
TW (2) TWI374739B (OSRAM)
UY (1) UY28861A1 (OSRAM)
WO (1) WO2005102349A1 (OSRAM)
ZA (1) ZA200606624B (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE102004024452A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation von Betaagonisten
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US7923455B2 (en) * 2005-01-28 2011-04-12 Boehringer Ingelheim International Gmbh Medicaments for the prevention or treatment of heart failure comprising administration of an anticholinergic
EP1855689A1 (en) * 2005-02-16 2007-11-21 Boehringer Ingelheim International GmbH Pharmaceutical compositions comprising anticholinergics and etiprednol
KR101360803B1 (ko) 2005-08-15 2014-02-11 베링거 인겔하임 인터내셔날 게엠베하 베타모방제의 제조방법
TWI389692B (zh) 2005-10-10 2013-03-21 Boehringer Ingelheim Int 用以吸入β-共效劑的氣溶膠調配物
US20070086957A1 (en) * 2005-10-10 2007-04-19 Thierry Bouyssou Combination of medicaments for the treatment of respiratory diseases
CA2627982C (en) * 2005-11-10 2013-09-10 Nicholas S. Bodor Soft anticholinergic esters
WO2007093608A1 (de) * 2006-02-16 2007-08-23 Boehringer Ingelheim International Gmbh Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
CA2660186A1 (en) * 2006-08-07 2008-02-14 Boehringer Ingelheim International Gmbh Pharmaceutical combinations for the treatment of respiratory diseases
UY30542A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de agonistas beta
UY30543A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
EP2086641A2 (en) * 2006-10-26 2009-08-12 Boehringer Ingelheim International GmbH Egfr kinase inhibitor combinations for the treatment of respiratory and gastrointestinal disorders
EP1921070A1 (de) 2006-11-10 2008-05-14 Boehringer Ingelheim Pharma GmbH & Co. KG Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung
EP2245026B1 (de) 2008-02-07 2012-08-01 Boehringer Ingelheim International GmbH Spirocyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
CA2733153C (en) 2008-08-08 2016-11-08 Boehringer Ingelheim International Gmbh Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them
JP2012509922A (ja) * 2008-11-27 2012-04-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規粉末化結晶質吸入薬
WO2014016548A2 (en) 2012-07-27 2014-01-30 Cipla Limited Pharmaceutical composition
WO2014056840A1 (en) * 2012-10-09 2014-04-17 Boehringer Ingelheim International Gmbh Beta-2-adrenoceptor agonist for the treatment of cough

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
US4570630A (en) 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
FI88112C (fi) 1985-07-30 1993-04-13 Glaxo Group Ltd Anordning foer administrering av laekemedel till patienter
SE453566B (sv) 1986-03-07 1988-02-15 Draco Ab Anordning vid pulverinhalatorer
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE4318455A1 (de) 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
HRP20020845A2 (en) * 2000-04-27 2003-10-31 Boehringer Ingelheim Pharma Novel, slow-acting betamimetics, a method for their production and their use as medicaments
PL207870B1 (pl) 2000-10-12 2011-02-28 Boehringer Ingelheim Pharma Krystaliczny monohydrat bromku tiotropium, sposób jego wytwarzania, środek leczniczy i zastosowanie
EP1401445B1 (de) 2001-06-22 2006-08-23 Boehringer Ingelheim Pharma GmbH & Co.KG Kristallines anticholinergikum, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
ES2203327B1 (es) * 2002-06-21 2005-06-16 Almirall Prodesfarma, S.A. Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.
DE10230751A1 (de) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und EGFR-Kinase-Hemmern
DE10246374A1 (de) * 2002-10-04 2004-04-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Betamimetika mit verlängerter Wirkungsdauer, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung

Also Published As

Publication number Publication date
NO2016022I1 (no) 2016-12-01
BE2015C065I2 (OSRAM) 2024-08-08
ATE539754T1 (de) 2012-01-15
CY1115719T1 (el) 2017-01-25
DK2422786T3 (da) 2014-11-17
ES2523518T3 (es) 2014-11-26
PT1781298E (pt) 2012-02-03
PL1781298T3 (pl) 2012-06-29
WO2005102349A1 (de) 2005-11-03
FR16C0029I1 (OSRAM) 2016-08-26
PT2422786E (pt) 2014-11-12
ECSP066947A (es) 2007-01-26
KR20070015592A (ko) 2007-02-05
TWI374739B (en) 2012-10-21
AU2005235419A1 (en) 2005-11-03
DK1781298T3 (da) 2012-05-07
SI1781298T1 (sl) 2012-04-30
FIC20170005I1 (fi) 2017-01-13
HUS1500058I1 (hu) 2016-01-28
EA200601846A1 (ru) 2007-04-27
LU93066I2 (fr) 2016-07-11
EP1781298A1 (de) 2007-05-09
CY2017014I2 (el) 2017-11-14
TWI372056B (en) 2012-09-11
SI2422786T1 (sl) 2014-12-31
PL2422786T3 (pl) 2015-02-27
ES2380370T3 (es) 2012-05-11
NO20065060L (no) 2006-11-21
IL177685A0 (en) 2006-12-31
NZ550797A (en) 2010-08-27
TW201231055A (en) 2012-08-01
NL300779I2 (nl) 2017-11-02
NO2016022I2 (no) 2016-12-01
BRPI0510080B1 (pt) 2020-08-18
IL177685A (en) 2013-10-31
NO337714B1 (no) 2016-06-06
PL1781298T4 (pl) 2017-07-31
CA2559699A1 (en) 2005-11-03
EP2422786B1 (de) 2014-08-13
EA013157B1 (ru) 2010-02-26
EP1781298B1 (de) 2012-01-04
AU2005235419B2 (en) 2010-11-04
PE20060462A1 (es) 2006-06-19
AR049262A1 (es) 2006-07-12
KR101287460B1 (ko) 2013-07-23
JP2007533683A (ja) 2007-11-22
CY2017014I1 (el) 2017-11-14
KR20130049840A (ko) 2013-05-14
CA2559699C (en) 2012-06-19
ZA200606624B (en) 2008-01-08
LTC1781298I2 (lt) 2018-09-25
CY1113890T1 (el) 2016-07-27
BRPI0510080A (pt) 2007-10-16
SG152237A1 (en) 2009-05-29
FR16C0029I2 (fr) 2017-01-27
EP2422786A1 (de) 2012-02-29
IL226562A0 (en) 2013-06-27
BRPI0510080B8 (pt) 2021-05-25
UY28861A1 (es) 2005-11-30

Similar Documents

Publication Publication Date Title
MY148945A (en) Combination of a betamimetic with anticholinergics and/or steroids
TW200801003A (en) Novel compounds
TW200800999A (en) Novel compounds
WO2005055983A3 (en) Method of preparation of mixed phase co-crystals with active agents
WO2008121348A8 (en) Peripheral opioid receptor antagonists and uses thereof
EA201000436A1 (ru) Стероидные [3,2-с]пиразольные соединения, обладающие глюкокортикоидной активностью
TW200716628A (en) Novel compounds
EP2279732A3 (en) Compounds and compositions for delivering active agents
ZA200809714B (en) Synergistic active ingredient combinations
SE0402925D0 (sv) Novel Compounds
TW200730178A (en) Aerosol formulations for the inhalation of β-agonists
TW200731975A (en) Novel combinations of medicaments for the treatment of respiratory diseases
TW200639156A (en) New compounds
SE0401763D0 (sv) Compounds
TW200626581A (en) Compounds, compositions containing them, preparation thereof and uses thereof
WO2010054606A3 (en) Triperpenoid 2 - deoxy glycosides and use thereof as medicaments
TW200800993A (en) Organic compounds
WO2008023003A8 (de) Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
TW200640911A (en) Novel, long acting betamimetics for the treatment of respiratory diseases
MY148403A (en) Aerosol formulation for the inhalation of beta-agonists
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
WO2007064620A3 (en) Compositions comprising a combination of ccr5 and cxcr4 antagonists
WO2006128847A3 (en) Medicament containing a betamimetic in conjunction with an anticholinergic and a pde iv inhibitor
TW200740440A (en) Novel combinations of medicaments for the treatment of respiratory diseases containing long-acting beta-agonists and at least one additional active ingredient
SE0400285D0 (sv) Pyrroloquinoline and piperidoquinoline derivatives, preparation thereof, compositions containing them and uses thereof